FSD Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 14, 2023 at 09:20 pm
FSD Pharma Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 1.06 million compared to USD 7.13 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.19 a year ago. Diluted loss per share from continuing operations was USD 0.03 compared to USD 0.19 a year ago.
For the nine months, net loss was USD 16.51 million compared to USD 17.46 million a year ago. Basic loss per share from continuing operations was USD 0.42 compared to USD 0.53 a year ago. Diluted loss per share from continuing operations was USD 0.42 compared to USD 0.53 a year ago.